Work

Gender Disparities in Statin Prescriptions in People With HIV With Low/Moderate to High Cardiovascular Risk

Year: 2024

Type: article

Abstract: The REPRIEVE trial suggests that primary cardiovascular disease (CVD) prevention could be considered among people with HIV at low CVD risk. We found cisgender women with low/moderate and high CVD risk are less likely to receive statins than cisgender men. Efforts are needed to guarantee equal access to statin-based CVD prevention.

Source: Zurich Open Repository and Archive (University of Zurich)

DOI: 10.5167/uzh-266737

Authors: Abela, Irene A, Chammartin, Frédérique, Amstutz, Alain, Surial, Bernard, Ballif, Marie, Marzolini, Catia, Aebi-Popp, Karoline, Notter, Julia, Segeral, Olivier, Stoeckle, Marcel, Cavassini, Matthias, Bernasconi, Enos, Günthard, Huldrych F, Kouyos, Roger D, Pasin, Chloé, Swiss HIV Cohort Study

Language: English

Topic: Lipoproteins and Cardiovascular Health

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDGs: Good health and well-being, Reduced inequalities

Open Access status: green

OpenAlex ID: W6948538467

FWCI:

Cites:

Cited by:

Related to: